Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001121404-23-000010
Filing Date
2023-04-27
Accepted
2023-04-27 11:39:42
Documents
5
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 6-K a6kcoverpagepressreleaseq1.htm 6-K 14774
2 EX-99.1 pressreleaseq12023english.htm EX-99.1 617926
3 GRAPHIC chart-7f33e0548ec048fabf5a.jpg GRAPHIC 77319
4 GRAPHIC imagea.jpg GRAPHIC 4047
5 GRAPHIC ratingagenciesq123a.jpg GRAPHIC 62545
  Complete submission text file 0001121404-23-000010.txt   832494
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

IRS No.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 23853423
SIC: 2834 Pharmaceutical Preparations